Literature for peptidase S01.300: kallikrein-related peptidase 7

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Inhibitors Pharma

(Topics flags: A Assay, S Structure, T Target, P Specificity, K Knockout, V Review, M Mutation, R Splicing, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

    2026
  1. Zingkou,E., Bisyris,E., Pampalakis,G. and Sotiropoulou,G.
    Dysregulated proteolytic cascades in Netherton syndrome: from molecular pathology to preclinical drug testing
    J Pathol (2026) PubMed  Europe PubMed DOI
  2. 2024
  3. Boumali,R., Urli,L., Naim,M., Soualmia,F., Kinugawa,K., Petropoulos,I. and El Amri,C.
    Kallikrein-related peptidase's significance in Alzheimer's disease pathogenesis: A comprehensive survey
    Biochimie (2024) 226, 77-90. PubMed  Europe PubMed DOI
  4. 2023
  5. Xu,J., Ye,W., Yang,T.T., Yan,T., Cai,H., Zhou,A. and Yang,Y.
    DNA accelerates the protease inhibition of a bacterial serpin chloropin
    Front Mol Biosci (2023) 10, 1157186-1157186. PubMed  Europe PubMed DOI  PMC  EPMC
  6. 2022
  7. Gonschorek,P., Zorzi,A., Maric,T., Le Jeune,M., Schuttel,M., Montagnon,M., Gomez-Ojea,R., Vollmar,D.P., Whitfield,C., Reymond,L., Carle,V., Verma,H., Schilling,O., Hovnanian,A. and Heinis,C.
    Phage Display Selected Cyclic Peptide Inhibitors of Kallikrein-Related Peptidases 5 and 7 and Their In Vivo Delivery to the Skin
    J Med Chem (2022) 65, 9735-9749. PubMed  Europe PubMed DOI
  8. Xiang,F., Wang,Y., Cao,C., Li,Q., Deng,H., Zheng,J., Liu,X. and Tan,X.
    The Role of Kallikrein 7 in Tumorigenesis
    Curr Med Chem (2022) 29, 2617-2631. PubMed  Europe PubMed DOI  V
  9. Yin,N., Pan,F., Qiu,L., Yang,Z., Xiong,R., Shi,L., Shi,Y., Wu,N., Wu,K., Li,Q., Wen,D., Huang,Q., Zhang,Y., Mi,Y. and Ji,Q.
    Vaspin Alleviates Sepsis-Induced Cardiac Injury and Cardiac Inflammation by Inhibiting Kallikrein 7 in Mice
    Mediators Inflamm (2022) 2022, 1149582-1149582. PubMed  Europe PubMed DOI  PMC  EPMC
  10. 2021
  11. Bisyris,E., Zingkou,E., Kordopati,G.G., Matsoukas,M., Magriotis,P.A., Pampalakis,G. and Sotiropoulou,G.
    A novel theranostic activity-based probe targeting kallikrein 7 for the diagnosis and treatment of skin diseases
    Chem Commun (Camb) (2021) 57, 6507-6510. PubMed  Europe PubMed DOI
  12. Kunath,A., Weiner,J., Krause,K., Rehders,M., Pejkovska,A., Gericke,M., Biniossek,M.L., Dommel,S., Kern,M., Ribas-Latre,A., Schilling,O., Brix,K., Stumvoll,M., Kloting,N., Heiker,J.T. and Bluher,M.
    Role of Kallikrein 7 in Body Weight and Fat Mass Regulation
    Biomedicines (2021) 9 PubMed  Europe PubMed DOI  PMC  EPMC
  13. Yeo,H., Ahn,S.S., Lee,J.Y. and Shin,S.Y.
    EGR-1 acts as a transcriptional activator of KLK7 under IL-13 stimulation
    Biochem Biophys Res Commun (2021) 534, 303-309. PubMed  Europe PubMed DOI  K
  14. Zani,M.B., Sant'Ana,A.M., Tognato,R.C., Chagas,J.R. and Puzer,L.
    Human Tissue Kallikreins-Related Peptidases Are Targets for the Treatment of Skin Desquamation Diseases
    Front Med (Lausanne) (2021) 8, 777619-777619. PubMed  Europe PubMed DOI  PMC  EPMC  V
  15. 2020
  16. Guo,C.J., Mack,M.R., Oetjen,L.K., Trier,A.M., Council,M.L., Pavel,A.B., Guttman-Yassky,E., Kim,B.S. and Liu,Q.
    Kallikrein 7 promotes atopic dermatitis-associated itch independently of skin inflammation
    J Invest Dermatol (2020) 140, 1244-1252. PubMed  Europe PubMed DOI
  17. Hanke,S., Tindall,C., Pippel,J., Ulbricht,D., Pirotte,B., Reboud-Ravaux,M., Heiker,J.T. and Strater,N.
    Structural studies on the inhibitory binding mode of aromatic coumarinic esters to human kallikrein-related peptidase 7
    J Med Chem (2020) PubMed  Europe PubMed DOI  I
  18. Kumar,D.V., Sivaranjani,Y. and Rao,G.V.
    Immunohistochemical expression of kallikrein 7 in oral squamous cell carcinoma
    J Oral Maxillofac Pathol (2020) 24, 580-580. PubMed  Europe PubMed DOI  PMC  EPMC
  19. Lim,S.C., Kee,K.H., Lee,M.J., Hong,R. and Han,S.I.
    Extracellular acidity induced expression of kallikrein related peptidases 7 and 8 is involved in increased invasiveness of gastric cancer cells
    Oncol Rep (2020) 43, 1705-1713. PubMed  Europe PubMed DOI
  20. 2019
  21. Dan,L. and Yonggang,L.
    Molecular characteristics and association analysis with litter size trait for porcine KLK7 gene
    Anim Biotechnol (2019) , 1-5. PubMed  Europe PubMed DOI
  22. Li,M., Srp,J., Gustchina,A., Dauter,Z., Mares,M. and Wlodawer,A.
    Crystal structures of the complex of a kallikrein inhibitor from Bauhinia bauhinioides with trypsin and modeling of kallikrein complexes
    Acta Crystallogr D Struct Biol (2019) 75, 56-69. PubMed  Europe PubMed DOI  S
  23. Murafuji,H., Muto,T., Goto,M., Imajo,S., Sugawara,H., Oyama,Y., Minamitsuji,Y., Miyazaki,S., Murai,K. and Fujioka,H.
    Discovery and structure-activity relationship of imidazolinylindole derivatives as kallikrein 7 inhibitors
    Bioorg Med Chem Lett (2019) 29, 334-338. PubMed  Europe PubMed DOI  I
  24. Silva,L.M., Kryza,T., Stoll,T., Hoogland,C., Dong,Y., Stephens,C.R., Hastie,M.L., Magdolen,V., Kleifeld,O., Gorman,J.J. and Clements,J.A.
    Integration of two in-depth quantitative proteomics approaches determines the kallikrein-related peptidase 7 (KLK7) degradome in ovarian cancer cell secretome
    Mol Cell Proteomics (2019) 18, 818-836. PubMed  Europe PubMed DOI  P
  25. 2018
  26. Al-Awadhi,F.H., Gao,B., Rezaei,M.A., Kwan,J.C., Li,C., Ye,T., Paul,V.J. and Luesch,H.
    Discovery, synthesis, pharmacological profiling, and biological characterization of brintonamides A-E, novel dual protease and GPCR modulators from a marine cyanobacterium
    J Med Chem (2018) 61, 6364-6378. PubMed  Europe PubMed DOI  I
  27. Du,J.P., Li,L., Zheng,J., Zhang,D., Liu,W., Zheng,W.H., Li,X.S., Yao,R.C., Wang,F., Liu,S. and Tan,X.
    Kallikrein-related peptidase 7 is a potential target for the treatment of pancreatic cancer
    Oncotarget (2018) 9, 12894-12906. PubMed  Europe PubMed DOI  PMC  EPMC  K  T
  28. Horn,M., Zbodakova,O., Kasparek,P., Srp,J., Haneckova,R., Hradilek,M., Mares,M. and Sedlacek,R.
    Profiling system for skin kallikrein proteolysis applied in gene-deficient mouse models
    Biol Chem (2018) 399, 1085-1089. PubMed  Europe PubMed DOI  A
  29. Kidana,K., Tatebe,T., Ito,K., Hara,N., Kakita,A., Saito,T., Takatori,S., Ouchi,Y., Ikeuchi,T., Makino,M., Saido,T.C., Akishita,M., Iwatsubo,T., Hori,Y. and Tomita,T.
    Loss of kallikrein-related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice
    EMBO Mol Med (2018) 10, e8184-e8184. PubMed  Europe PubMed DOI  K
  30. Murafuji,H., Sakai,H., Goto,M., Oyama,Y., Imajo,S., Sugawara,H., Tomoo,T. and Muto,T.
    Structure-based drug design of 1,3,6-trisubstituted 1,4-diazepan-7-ones as selective human kallikrein 7 inhibitors
    Bioorg Med Chem Lett (2018) 28, 1371-1375. PubMed  Europe PubMed DOI  I
  31. Murafuji,H., Sugawara,H., Goto,M., Oyama,Y., Sakai,H., Imajo,S., Tomoo,T. and Muto,T.
    Structure-based drug design to overcome species differences in kallikrein 7 inhibition of 1,3,6-trisubstituted 1,4-diazepan-7-ones
    Bioorg Med Chem (2018) 26, 3639-3653. PubMed  Europe PubMed DOI  S  I
  32. Zieger,K., Weiner,J., Kunath,A., Gericke,M., Krause,K., Kern,M., Stumvoll,M., Kloting,N., Bluher,M. and Heiker,J.T.
    Ablation of kallikrein 7 (KLK7) in adipose tissue ameliorates metabolic consequences of high fat diet-induced obesity by counteracting adipose tissue inflammation in vivo
    Cell Mol Life Sci (2018) 75, 727-742. PubMed  Europe PubMed DOI  K
  33. 2017
  34. Adamopoulos,P.G., Kontos,C.K. and Scorilas,A.
    Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 - KLK9), using Next-generation sequencing
    Sci Rep (2017) 7, 17299-17299. PubMed  Europe PubMed DOI  PMC  EPMC  M
  35. de Veer,S.J., Furio,L., Swedberg,J.E., Munro,C.A., Brattsand,M., Clements,J.A., Hovnanian,A. and Harris,J.M.
    Selective substrates and inhibitors for kallikrein-related peptidase 7 (KLK7) shed light on KLK proteolytic activity in the stratum corneum
    J Invest Dermatol (2017) 137, 430-439. PubMed  Europe PubMed DOI
  36. Igawa,S., Kishibe,M., Minami-Hori,M., Honma,M., Tsujimura,H., Ishikawa,J., Fujimura,T., Murakami,M. and Ishida-Yamamoto,A.
    Incomplete KLK7 secretion and upregulated LEKTI expression underlie hyperkeratotic stratum corneum in atopic dermatitis
    J Invest Dermatol (2017) 137, 449-456. PubMed  Europe PubMed DOI
  37. Kasparek,P., Ileninova,Z., Zbodakova,O., Kanchev,I., Benada,O., Chalupsky,K., Brattsand,M., Beck,I.M. and Sedlacek,R.
    KLK5 and KLK7 ablation fully rescues lethality of Netherton syndrome-like phenotype
    PLoS Genet (2017) 13, e1006566-e1006566. PubMed  Europe PubMed DOI  K
  38. McGovern,J.A., Meinert,C., deVeer,S.J., Hollier,B.G., Parker,T.J. and Upton,Z.
    Attenuated kallikrein-related peptidase activity disrupts desquamation and leads to stratum corneum thickening in human skin equivalent models
    Br J Dermatol (2017) 176, 145-158. PubMed  Europe PubMed DOI
  39. Murafuji,H., Sakai,H., Goto,M., Imajo,S., Sugawara,H. and Muto,T.
    Discovery and structure-activity relationship study of 1,3,6-trisubstituted 1,4-diazepane-7-ones as novel human kallikrein 7 inhibitors
    Bioorg Med Chem Lett (2017) 27, 5272-5276. PubMed  Europe PubMed DOI  I
  40. Silva,L.M., Stoll,T., Kryza,T., Stephens,C.R., Hastie,M.L., Irving-Rodgers,H.F., Dong,Y., Gorman,J.J. and Clements,J.A.
    Mass spectrometry-based determination of kallikrein-related peptidase 7 (KLK7) cleavage preferences and subsite dependency
    Sci Rep (2017) 7, 6789-6789. PubMed  Europe PubMed DOI  PMC  EPMC  P
  41. Zheng,X., He,M., Tan,X., Zheng,J., Wang,F. and Liu,S.
    3D-Quantitative structure-activity relationship and docking studies of coumarin derivatives as tissue kallikrein 7 inhibitors
    J Pharm Pharmacol (2017) 69, 1136-1144. PubMed  Europe PubMed DOI  I
  42. 2016
  43. Chen,W., Kinsler,V.A., Macmillan,D. and Di,W.L.
    Tissue kallikrein inhibitors based on the sunflower trypsin inhibitor scaffold - a potential therapeutic intervention for skin diseases
    PLoS ONE (2016) 11, e0166268-e0166268. PubMed  Europe PubMed DOI  PMC  EPMC
  44. Karakosta,T.D., Soosaipillai,A., Diamandis,E.P., Batruch,I. and Drabovich,A.P.
    Quantification of human kallikrein-related peptidases in biological fluids by multiplatform targeted mass spectrometry assays
    Mol Cell Proteomics (2016) 15, 2863-2876. PubMed  Europe PubMed DOI  A
  45. Maibaum,J., Liao,S.M., Vulpetti,A., Ostermann,N., Randl,S., Rudisser,S., Lorthiois,E., Erbel,P., Kinzel,B., Kolb,F.A., Barbieri,S., Wagner,J., Durand,C., Fettis,K., Dussauge,S., Hughes,N., Delgado,O., Hommel,U., Gould,T., Mac Sweeney,A., Gerhartz,B., Cumin,F., Flohr,S., Schubart,A., Jaffee,B., Harrison,R., Risitano,A.M., Eder,J. and Anderson,K.
    Small-molecule factor D inhibitors targeting the alternative complement pathway
    Nat Chem Biol (2016) 12, 1105-1110. PubMed  Europe PubMed DOI  I
  46. 2015
  47. Arama,D.P., Soualmia,F., Lisowski,V., Longevial,J.F., Bosc,E., Maillard,L.T., Martinez,J., Masurier,N. and El Amri,C.
    Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7
    Eur J Med Chem (2015) 93C, 202-213. PubMed  Europe PubMed DOI  I
  48. Oliveira,J.R., Bertolin,T.C., Andrade,D., Oliveira,L.C., Kondo,M.Y., Santos,J.A., Blaber,M., Juliano,L., Severino,B., Caliendo,G., Santagada,V. and Juliano,M.A.
    Specificity studies on kallikrein-related peptidase 7 (KLK7) and effects of osmolytes and glycosaminoglycans on its peptidase activity
    Biochim Biophys Acta (2015) 1854, 73-83. PubMed  Europe PubMed DOI  A
  49. Tan,X., Soualmia,F., Furio,L., Renard,J.F., Kempen,I., Qin,L., Pagano,M., Pirotte,B., El Amri,C., Hovnanian,A. and Reboud-Ravaux,M.
    Toward the first class of suicide inhibitors of kallikreins involved in skin diseases
    J Med Chem (2015) 58, 598-612. PubMed  Europe PubMed DOI  I
  50. Yu,Y., Prassas,I., Dimitromanolakis,A. and Diamandis,E.P.
    Novel biological substrates of human kallikrein 7 identified through degradomics
    J Biol Chem (2015) 290, 17762-17775. PubMed  Europe PubMed DOI  P
  51. 2014
  52. Shropshire,T.D., Reifert,J., Rajagopalan,S., Baker,D., Feinstein,S.C. and Daugherty,P.S.
    Amyloid beta peptide cleavage by kallikrein 7 attenuates fibril growth and rescues neurons from Abeta-mediated toxicity in vitro
    Biol Chem (2014) 395, 109-118. PubMed  Europe PubMed DOI  P
  53. 2013
  54. de Veer,S.J., Ukolova,S.S., Munro,C.A., Swedberg,J.E., Buckle,A.M. and Harris,J.M.
    Mechanism-based selection of a potent kallikrein-related peptidase 7 inhibitor from a versatile library based on the sunflower trypsin inhibitor SFTI-1
    Biopolymers (2013) 100, 510-518. PubMed  Europe PubMed DOI
  55. Heiker,J.T., Kloting,N., Kovacs,P., Kuettner,E.B., Strater,N., Schultz,S., Kern,M., Stumvoll,M., Bluher,M. and Beck-Sickinger,A.G.
    Vaspin inhibits kallikrein 7 by serpin mechanism
    Cell Mol Life Sci (2013) 70, 2569-2583. PubMed  Europe PubMed DOI  S
  56. Lundwall,A.
    Old genes and new genes: The evolution of the kallikrein locus
    Thromb Haemost (2013) 110, 469-475. PubMed  Europe PubMed DOI  V
  57. Schultz,S., Saalbach,A., Heiker,J.T., Meier,R., Zellmann,T., Simon,J.C. and Beck-Sickinger,A.G.
    Proteolytic activation of prochemerin by kallikrein 7 breaks an ionic linkage and results in C-terminal rearrangement
    Biochem J (2013) 452, 271-280. PubMed  Europe PubMed DOI
  58. Tan,X., Furio,L., Reboud-Ravaux,M., Villoutreix,B.O., Hovnanian,A. and El Amri,C.
    1,2,4-Triazole derivatives as transient inactivators of kallikreins involved in skin diseases
    Bioorg Med Chem Lett (2013) 23, 4547-4551. PubMed  Europe PubMed DOI  I
  59. 2012
  60. Britland,S. and Hoyle,M.
    Transcriptional gene silencing of kallikrein 5 and kallikrein 7 using siRNA prevents epithelial cell detachment induced by alkaline shock in an in vitro model of eczema
    Biotechnol Prog (2012) 28, 485-489. PubMed  Europe PubMed DOI
  61. Clements,J.A., Hooper,J.D. and Dong,Y.
    The human tissue kallikrein and kallikrein-related peptidase family
    [ISSN:978-0-12-407742-3] (2012) 3, 2747-2756. DOI
  62. Farady,C.J., Mayr,L.M. and Kolb,F.A.
    Kallikrein-related peptidase 7
    [ISSN:978-0-12-407742-3] (2012) 3, 2788-2792. DOI
  63. Yamamoto,M., Miyai,M., Matsumoto,Y., Tsuboi,R. and Hibino,T.
    Kallikrein-related peptidase-7 regulates caspase-14 maturation during keratinocyte terminal differentiation by generating an intermediate form
    J Biol Chem (2012) 287, 32825-32834. PubMed  Europe PubMed DOI
  64. 2011
  65. Ramani,V.C., Kaushal,G.P. and Haun,R.S.
    Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains
    Biochim Biophys Acta (2011) 1813, 1525-1531. PubMed  Europe PubMed DOI
  66. Teixeira,T.S., Freitas,R.F., Abrahao,O., Jr., Devienne,K.F., de Souza,L.R., Blaber,S.I., Blaber,M., Kondo,M.Y., Juliano,M.A., Juliano,L. and Puzer,L.
    Biological evaluation and docking studies of natural isocoumarins as inhibitors for human kallikrein 5 and 7
    Bioorg Med Chem Lett (2011) 21, 6112-6115. PubMed  Europe PubMed DOI  I
  67. 2010
  68. Angelopoulou,K. and Karagiannis,G.S.
    Structural characterization and expression of five novel canine kallikrein-related peptidases in mammary cancer
    Mamm Genome (2010) 21, 516-524. PubMed  Europe PubMed DOI
  69. Mo,L., Zhang,J., Shi,J., Xuan,Q., Yang,X., Qin,M., Lee,C., Klocker,H., Li,Q.Q. and Mo,Z.
    Human kallikrein 7 induces epithelial-mesenchymal transition-like changes in prostate carcinoma cells: a role in prostate cancer invasion and progression
    Anticancer Res (2010) 30, 3413-3420. PubMed  Europe PubMed
  70. 2009
  71. Doering,K., Meder,G., Hinnenberger,M., Woelcke,J., Mayr,L.M. and Hassiepen,U.
    A fluorescence lifetime-based assay for protease inhibitor profiling on human kallikrein 7
    J Biomol Screen (2009) 14, 1-9. PubMed  Europe PubMed DOI  A
  72. Talieri,M., Mathioudaki,K., Prezas,P., Alexopoulou,D.K., Diamandis,E.P., Xynopoulos,D., Ardavanis,A., Arnogiannaki,N. and Scorilas,A.
    Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer
    Thromb Haemost (2009) 101, 741-747. PubMed  Europe PubMed DOI
  73. 2008
  74. Clements,J.A.
    Reflections on the tissue kallikrein and kallikrein-related peptidase family - from mice to men - what have we learnt in the last two decades?
    Biol Chem (2008) 389, 1447-1454. PubMed  Europe PubMed DOI  V
  75. Debela,M., Beaufort,N., Magdolen,V., Schechter,N.M., Craik,C.S., Schmitt,M., Bode,W. and Goettig,P.
    Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7
    Biol Chem (2008) 389, 623-632. PubMed  Europe PubMed DOI  P  S
  76. Dong,Y., Matigian,N., Harvey,T.J., Samaratunga,H., Hooper,J.D. and Clements,J.A.
    Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic function
    Biol Chem (2008) 389, 99-109. PubMed  Europe PubMed DOI
  77. Psyrri,A., Kountourakis,P., Scorilas,A., Markakis,S., Camp,R., Kowalski,D., Diamandis,E.P. and Dimopoulos,M.A.
    Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression
    Ann Oncol (2008) 19, 1271-1277. PubMed  Europe PubMed DOI
  78. Ramani,V.C., Hennings,L. and Haun,R.S.
    Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer
    BMC Cancer (2008) 8, 373-373. PubMed  Europe PubMed DOI  PMC  EPMC
  79. 2007
  80. Debela,M., Hess,P., Magdolen,V., Schechter,N.M., Steiner,T., Huber,R., Bode,W. and Goettig,P.
    Chymotryptic specificity determinants in the 1.0 A structure of the zinc-inhibited human tissue kallikrein 7
    Proc Natl Acad Sci U S A (2007) 104, 16086-16091. PubMed  Europe PubMed DOI  PMC  EPMC  S
  81. Deraison,C., Bonnart,C., Lopez,F., Besson,C., Robinson,R., Jayakumar,A., Wagberg,F., Brattsand,M., Hachem,J.P., Leonardsson,G. and Hovnanian,A.
    LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction
    Mol Biol Cell (2007) 18, 3607-3619. PubMed  Europe PubMed DOI  PMC  EPMC
  82. Fernandez,I.S., Standker,L., Forssmann,W.G., Gimenez-Gallego,G. and Romero,A.
    Crystallization and preliminary crystallographic studies of human kallikrein 7, a serine protease of the multigene kallikrein family
    Acta Crystallograph Sect F Struct Biol Cryst Commun (2007) 63, 669-672. PubMed  Europe PubMed DOI  PMC  EPMC
  83. Fernando,S.C., Najar,F.Z., Guo,X., Zhou,L., Fu,Y., Geisert,R.D., Roe,B.A. and DeSilva,U.
    Porcine kallikrein gene family: genomic structure, mapping, and differential expression analysis
    Genomics (2007) 89, 429-438. PubMed  Europe PubMed DOI
  84. Johnson,S.K., Ramani,V.C., Hennings,L. and Haun,R.S.
    Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin
    Cancer (2007) 109, 1811-1820. PubMed  Europe PubMed DOI
  85. Shaw,J.L. and Diamandis,E.P.
    Distribution of 15 human kallikreins in tissues and biological fluids
    Clin Chem (2007) 53, 1423-1432. PubMed  Europe PubMed DOI
  86. Yoon,H., Laxmikanthan,G., Lee,J., Blaber,S.I., Rodriguez,A., Kogot,J.M., Scarisbrick,I.A. and Blaber,M.
    Activation profiles and regulatory cascades of the human kallikrein-related peptidases
    J Biol Chem (2007) 282, 31852-31864. PubMed  Europe PubMed DOI  V
  87. Zakabunin,A.I., Mishukova,O.V., Khrapov,E.A., Sergeichev,D.S., Boiarskikh,U.A., Sverdlov,E.D. and Filipenko,M.L.
    [Cloning and expression of the gene of chymotrypsin-like protease of human kallikrein-7 in Escherichia coli and isolation of recombinant protein]
    Mol Gen Mikrobiol Virusol (2007) 2007, 21-25. PubMed  Europe PubMed
  88. 2006
  89. [YEAR:1-6-2006]Debela,M., Magdolen,V., Schechter,N., Valachova,M., Lottspeich,F., Craik,C.S., Choe,Y., Bode,W. and Goettig,P.
    Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences
    J Biol Chem (1-6-2006) 281, 25678-25688. PubMed  Europe PubMed DOI  P
  90. [YEAR:20-4-2006]Holzscheiter,L., Biermann,J.C., Kotzsch,M., Prezas,P., Farthmann,J., Baretton,G., Luther,T., Tjan-Heijnen,V.C., Talieri,M., Schmitt,M., Sweep,F.C., Span,P.N. and Magdolen,V.
    Quantitative reverse transcription-PCR assay for detection of mRNA encoding full-length human tissue kallikrein 7: prognostic relevance of KLK7 mRNA expression in breast cancer
    Clin Chem (20-4-2006) 52, 1070-1079. PubMed  Europe PubMed DOI
  91. Luo,L.Y. and Jiang,W.
    Inhibition profiles of human tissue kallikreins by serine protease inhibitors
    Biol Chem (2006) 387, 813-816. PubMed  Europe PubMed DOI
  92. Prezas,P., Arlt,M.J., Viktorov,P., Soosaipillai,A., Holzscheiter,L., Schmitt,M., Talieri,M., Diamandis,E.P., Kruger,A. and Magdolen,V.
    Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells
    Biol Chem (2006) 387, 807-811. PubMed  Europe PubMed DOI
  93. Stenshamn,K., Bongcam-Rudloff,E., Salmon Hillbertz,N., Nodtvedt,A., Bergvall,K., Hedhammar,A. and Andersson,G.
    Evaluation of kallikrein 7 as a disease-causing gene for canine atopic dermatitis using microsatellite-based association mapping
    Anim Genet (2006) 37, 601-603. PubMed  Europe PubMed DOI
  94. 2005
  95. [YEAR:1-5-2005]Bondurant,K.L., Crew,M.D., Santin,A.D., O'Brien,T.J. and Cannon,M.J.
    Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme
    Clin Cancer Res (1-5-2005) 11, 3446-3454. PubMed  Europe PubMed DOI
  96. Egelrud,T., Brattsand,M., Kreutzmann,P., Walden,M., Vitzithum,K., Marx,U.C., Forssmann,W.G. and Magert,H.J.
    hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6
    Br J Dermatol (2005) 153, 1200-1203. PubMed  Europe PubMed DOI  P
  97. [YEAR:25-5-2005]Kurlender,L., Borgono,C., Michael,I.P., Obiezu,C., Elliott,M.B., Yousef,G.M. and Diamandis,E.P.
    A survey of alternative transcripts of human tissue kallikrein genes
    Biochim Biophys Acta (25-5-2005) 1755, 1-14. PubMed  Europe PubMed DOI  R
  98. Schechter,N.M., Choi,E.J., Wang,Z.M., Hanakawa,Y., Stanley,J.R., Kang,Y., Clayman,G.L. and Jayakumar,A.
    Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI)
    Biol Chem (2005) 386, 1173-1184. PubMed  Europe PubMed DOI
  99. 2004
  100. Caubet,C., Jonca,N., Brattsand,M., Guerrin,M., Bernard,D., Schmidt,R., Egelrud,T., Simon,M. and Serre,G.
    Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7
    J Invest Dermatol (2004) 122, 1235-1244. PubMed  Europe PubMed DOI
  101. Clements,J.A., Hooper,J.D., Odorico,D.M. and Dong,Y.
    The tissue kallikrein gene cluster
    [ISSN:0-12-079610-4] (2004) 2, 1569-1577.  V
  102. Egelrud,T.
    Stratum corneum chymotryptic enzyme
    [ISSN:0-12-079610-4] (2004) 2, 1556-1558.  V
  103. [YEAR:5-2-2004]Kishi,T., Soosaipillai,A., Grass,L., Little,S.P., Johnstone,E.M. and Diamandis,E.P.
    Development of an immunofluorometric assay and quantification of human kallikrein 7 in tissue extracts and biological fluids
    Clin Chem (5-2-2004) 50, 709-716. PubMed  Europe PubMed DOI  A
  104. Ny,A. and Egelrud,T.
    Epidermal hyperproliferation and decreased skin barrier function in mice overexpressing stratum corneum chymotryptic enzyme
    Acta Derm Venereol (2004) 84, 18-22. PubMed  Europe PubMed DOI
  105. Santin,A.D., Cane',S., Bellone,S., Bignotti,E., Palmieri,M., De Las Casas,L.E., Roman,J.J., Anfossi,S., O'Brien,T. and Pecorelli,S.
    The serine protease stratum corneum chymotryptic enzyme (kallikrein 7) is highly overexpressed in squamous cervical cancer cells
    Gynecol Oncol (2004) 94, 283-288. PubMed  Europe PubMed DOI
  106. Talieri,M., Diamandis,E.P., Gourgiotis,D., Mathioudaki,K. and Scorilas,A.
    Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma
    Thromb Haemost (2004) 91, 180-186. PubMed  Europe PubMed DOI
  107. Vasilopoulos,Y., Cork,M.J., Murphy,R., Williams,H.C., Robinson,D.A., Duff,G.W., Ward,S.J. and Tazi-Ahnini,R.
    Genetic association between an AACC insertion in the 3'UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis
    J Invest Dermatol (2004) 123, 62-66. PubMed  Europe PubMed DOI  M
  108. 2003
  109. Kyriakopoulou,L.G., Yousef,G.M., Scorilas,A., Katsaros,D., Massobrio,M., Fracchioli,S. and Diamandis,E.P.
    Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer
    Clin Biochem (2003) 36, 135-143. PubMed  Europe PubMed DOI
  110. Ny,A. and Egelrud,T.
    Transgenic mice over-expressing a serine protease in the skin: evidence of interferon gamma-independent MHC II expression by epidermal keratinocytes
    Acta Derm Venereol (2003) 83, 322-327. PubMed  Europe PubMed DOI
  111. [YEAR:1-5-2003]Yousef,G.M., Polymeris,M.E., Yacoub,G.M., Scorilas,A., Soosaipillai,A., Popalis,C., Fracchioli,S., Katsaros,D. and Diamandis,E.P.
    Parallel overexpression of seven kallikrein genes in ovarian cancer
    Cancer Res (1-5-2003) 63, 2223-2227. PubMed  Europe PubMed
  112. 2002
  113. Hansson,L., Backman,A., Ny,A., Edlund,M., Ekholm,E., Ekstrand Hammarstrom,B., Tornell,J., Wallbrandt,P., Wennbo,H. and Egelrud,T.
    Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis
    J Invest Dermatol (2002) 118, 444-449. PubMed  Europe PubMed DOI
  114. 2001
  115. Clements,J., Hooper,J., Dong,Y. and Harvey,T.
    The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions
    Biol Chem (2001) 382, 5-14. PubMed  Europe PubMed DOI  V
  116. 2000
  117. Egelrud,T.
    Desquamation in the stratum corneum
    Acta Derm Venereol Suppl (Stockh) (2000) 208, 44-45. PubMed  Europe PubMed
  118. [YEAR:22-8-2000]Yousef,G.M., Scorilas,A., Magklara,A., Soosaipillai,A. and Diamandis,E.P.
    The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family - genomic characterization, mapping, tissue expression and hormonal regulation
    Gene (22-8-2000) 254, 119-128. PubMed  Europe PubMed DOI
  119. 1999
  120. Backman,A., Stranden,P., Brattsand,M., Hansson,L. and Egelrud,T.
    Molecular cloning and tissue expression of the murine analog to human stratum corneum chymotryptic enzyme
    J Invest Dermatol (1999) 113, 152-155. PubMed  Europe PubMed DOI
  121. [YEAR:15-11-1999]Tanimoto,H., Underwood,L.J., Shigemasa,K., Yan Yan,M.S., Clarke,J., Parmley,T.H. and O'Brien,T.J.
    The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells
    Cancer (15-11-1999) 86, 2074-2082. PubMed  Europe PubMed DOI
  122. 1998
  123. Ekholm,E., Sondell,B., Stranden,P., Brattsand,M. and Egelrud,T.
    Expression of stratum corneum chymotryptic enzyme in human sebaceous follicles
    Acta Derm Venereol (1998) 78, 343-347. PubMed  Europe PubMed
  124. Ekholm,E. and Egelrud,T.
    The expression of stratum corneum chymotryptic enzyme in human anagen hair follicles: further evidence for its involvement in desquamation-like processes
    Br J Dermatol (1998) 139, 585-590. PubMed  Europe PubMed DOI
  125. 1997
  126. Presland,R.B., Kimball,J.R., Kautsky,M.B., Lewis,S.P., Lo,C.Y. and Dale,B.A.
    Evidence for specific proteolytic cleavage of the N-terminal domain of human profilaggrin during epidermal differentiation
    J Invest Dermatol (1997) 108, 170-178. PubMed  Europe PubMed
  127. 1996
  128. Franzke,C.W., Baici,A., Bartels,J., Christophers,E. and Wiedow,O.
    Antileukoprotease inhibits stratum corneum chymotryptic enzyme. Evidence for a regulative function in desquamation
    J Biol Chem (1996) 271, 21886-21890. PubMed  Europe PubMed DOI
  129. Sondell,B., Dyberg,P., Anneroth,G.K., Ostman,P.O. and Egelrud,T.
    Association between expression of stratum corneum chymotryptic enzyme and pathological keratinization in human oral mucosa
    Acta Derm Venereol (1996) 76, 177-181. PubMed  Europe PubMed
  130. 1995
  131. Resing,K.A., Thulin,C., Whiting,K., al-Alawi,N. and Mostad,S.
    Characterization of profilaggrin endoproteinase 1. A regulated cytoplasmic endoproteinase of epidermis
    J Biol Chem (1995) 270, 28193-28198. PubMed  Europe PubMed DOI
  132. Skytt,A., Stromqvist,M. and Egelrud,T.
    Primary substrate specificity of recombinant human stratum corneum chymotryptic enzyme
    Biochem Biophys Res Commun (1995) 211, 586-589. PubMed  Europe PubMed DOI
  133. Sondell,B., Thornell,L.E. and Egelrud,T.
    Evidence that stratum corneum chymotryptic enzyme is transported to the stratum corneum extracellular space via lamellar bodies
    J Invest Dermatol (1995) 104, 819-823. PubMed  Europe PubMed
  134. 1994
  135. Hansson,L., Stromqvist,M., Backman,A., Wallbrandt,P., Carlstein,A. and Egelrud,T.
    Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase
    J Biol Chem (1994) 269, 19420-19426. PubMed  Europe PubMed
  136. Sondell,B., Thornell,L.E., Stigbrand,T. and Egelrud,T.
    Immunolocalization of stratum corneum chymotryptic enzyme in human skin and oral epithelium with monoclonal antibodies: evidence of a proteinase specifically expressed in keratinizing squamous epithelia
    J Histochem Cytochem (1994) 42, 459-465. PubMed  Europe PubMed
  137. 1993
  138. Egelrud,T., Regnier,M., Sondell,B., Shroot,B. and Schmidt,R.
    Expression of stratum corneum chymotryptic enzyme in reconstructed human epidermis and its suppression by retinoic acid
    Acta Derm Venereol (1993) 73, 181-184. PubMed  Europe PubMed
  139. Egelrud,T.
    Purification and preliminary characterization of stratum corneum chymotryptic enzyme: a proteinase that may be involved in desquamation
    J Invest Dermatol (1993) 101, 200-204. PubMed  Europe PubMed
  140. 1991
  141. Lundstrom,A. and Egelrud,T.
    Stratum corneum chymotryptic enzyme: a proteinase which may be generally present in the stratum corneum and with a possible involvement in desquamation
    Acta Derm Venereol (1991) 71, 471-474. PubMed  Europe PubMed
  142. 1990
  143. Lundstrom,A. and Egelrud,T.
    Cell shedding from human plantar skin in vitro: evidence that two different types of protein structures are degraded by a chymotrypsin-like enzyme
    Arch Dermatol Res (1990) 282, 234-237. PubMed  Europe PubMed DOI